Monarch Partners Asset Management LLC Rocket Pharmaceuticals, Inc. Transaction History
Monarch Partners Asset Management LLC
- $328 Million
- Q4 2022
A detailed history of Monarch Partners Asset Management LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Monarch Partners Asset Management LLC holds 113,788 shares of RCKT stock, worth $347,053. This represents 0.68% of its overall portfolio holdings.
Number of Shares
113,788
Previous 86,785
31.11%
Holding current value
$347,053
Previous $1.39 Million
60.72%
% of portfolio
0.68%
Previous 0.42%
Shares
8 transactions
Others Institutions Holding RCKT
# of Institutions
194Shares Held
96.4MCall Options Held
563KPut Options Held
418K-
Rtw Investments, LP New York, NY17.7MShares$53.9 Million0.77% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.47MShares$25.8 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.89MShares$21 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$18.9 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA3.9MShares$11.9 Million2.3% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $231M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...